Invited commentary.
Chambers
David J
DJ
Cardiac Surgical Research, The Rayne Institute, King's College London, Guy's and St. Thomas' NHS Foundation Trust, St. Thomas' Hospital, London, United Kingdom. david.chambers@kcl.ac.uk
D000818:Animals; D016572:Cyclosporine / Q000494:pharmacology*; D004195:Disease Models, Animal; D033681:Mitochondrial Membrane Transport Proteins / Q000187:drug effects / Q000378:metabolism*; D000083162:Mitochondrial Permeability Transition Pore; D017202:Myocardial Ischemia / Q000473:pathology / Q000628:therapy; D015428:Myocardial Reperfusion Injury / Q000517:prevention & control*; D011817:Rabbits; D012680:Sensitivity and Specificity; D016559:Tacrolimus / Q000494:pharmacology
D033681:Mitochondrial Membrane Transport Proteins; D000083162:Mitochondrial Permeability Transition Pore; D016572:Cyclosporine; D016559:Tacrolimus